PRRT2 and blood platelet disease: Heterozygous but especially homozygous mice displayed impaired platelet function characterized by decreased αIIbβ3 integrin activation, aggregation, and PKC α/β phosphorylation, demonstrating the role of the variant in platelet disorders [19].